1. Home
  2. WVE vs FL Comparison

WVE vs FL Comparison

Compare WVE & FL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • FL
  • Stock Information
  • Founded
  • WVE 2012
  • FL 1879
  • Country
  • WVE Singapore
  • FL United States
  • Employees
  • WVE N/A
  • FL N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • FL Clothing/Shoe/Accessory Stores
  • Sector
  • WVE Health Care
  • FL Consumer Discretionary
  • Exchange
  • WVE Nasdaq
  • FL Nasdaq
  • Market Cap
  • WVE 2.1B
  • FL 2.1B
  • IPO Year
  • WVE 2015
  • FL N/A
  • Fundamental
  • Price
  • WVE $13.70
  • FL $22.57
  • Analyst Decision
  • WVE Strong Buy
  • FL Hold
  • Analyst Count
  • WVE 10
  • FL 18
  • Target Price
  • WVE $21.60
  • FL $25.67
  • AVG Volume (30 Days)
  • WVE 947.4K
  • FL 5.0M
  • Earning Date
  • WVE 11-12-2024
  • FL 12-04-2024
  • Dividend Yield
  • WVE N/A
  • FL N/A
  • EPS Growth
  • WVE N/A
  • FL N/A
  • EPS
  • WVE N/A
  • FL N/A
  • Revenue
  • WVE $53,610,000.00
  • FL $8,124,000,000.00
  • Revenue This Year
  • WVE N/A
  • FL $2.77
  • Revenue Next Year
  • WVE $48.58
  • FL $2.53
  • P/E Ratio
  • WVE N/A
  • FL N/A
  • Revenue Growth
  • WVE N/A
  • FL 0.04
  • 52 Week Low
  • WVE $3.50
  • FL $19.33
  • 52 Week High
  • WVE $16.74
  • FL $35.60
  • Technical
  • Relative Strength Index (RSI)
  • WVE 48.19
  • FL 44.53
  • Support Level
  • WVE $13.11
  • FL $21.15
  • Resistance Level
  • WVE $15.54
  • FL $23.44
  • Average True Range (ATR)
  • WVE 0.89
  • FL 1.11
  • MACD
  • WVE -0.19
  • FL -0.01
  • Stochastic Oscillator
  • WVE 27.52
  • FL 45.67

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About FL Foot Locker Inc.

Foot Locker Inc operates thousands of retail stores throughout the United States, Canada, Europe, Asia, Australia, and New Zealand. It also has a presence in the Middle East. The company mainly sells athletically inspired shoes and apparel. Foot Locker's merchandise comes from only a few suppliers, with Nike providing the majority. Its portfolio of brands, includes Foot Locker, Kids Foot Locker, Champs Sports, WSS, and atmos. The company has omnichannel capabilities to bridge the digital world and physical stores, including order-in-store, buy online and pickup-in-store, and buy online and ship-from-store, as well as e-commerce. It has three operating segments, North America, EMEA, and Asia Pacific.

Share on Social Networks: